Cell and Gene Outsourcing

  1. Raising The Bar In Gene Therapy 12/1/2025

    Learn how a science-driven and digitally structured approach reduced onboarding timelines for gene therapy from 12 months to just 3, setting a new benchmark in technology transfers.

  2. Choosing The Right CDMO Partner For Your Biopharma Molecule 12/1/2025

    Selecting the right CDMO is critical for biopharma success. The ideal partner offers end-to-end capabilities, scientific expertise, quality culture, agility, and transparent collaboration from concept to commercialization.

  3. Accelerated LVV Manufacturing Enabled By Platform Excellence 11/25/2025

    Discover how a manufacturing platform enabled the rapid production of lentiviral vector in eight months. Learn the strategy used to balance speed, risk mitigation, and the highest quality standards.

  4. Efficient Late-Stage Development Of Biologics 11/25/2025

    Reducing biologics manufacturing costs requires strategic late-stage process development, yield optimization, scale-up, and raw material substitution—all while maintaining product quality and regulatory compliance.

  5. Comparing Gel, qPCR & HPLC For DNA/RNA Analysis 11/25/2025

    Cost-effective agarose gel electrophoresis offers reliable plasmid supercoil and host DNA/RNA quantification, providing a practical alternative to qPCR and HPLC for biomanufacturing quality control.

  6. The Future Of Biotech Outsourcing: Essential Skills For Program Managers 11/24/2025

    The next generation of program managers who liaise with contract manufacturers needs an expanded skillset to thrive.

  7. Custom Biospecimens Collections 11/17/2025

    With an in-house donor center and database of donors, along with an established network of hospitals and care centers, Precision can source virtually any disease type or sample type biospecimens needed for your project.

  8. How To Improve Sponsor–CMO Collaboration Around Digital Deviations 11/17/2025

    Digital strategies and standardized data models cut manual work, boost accuracy and speed of information sharing, and build trust between sponsors and CMOs.

  9. How One Biotech Company Is Accelerating The Drug Discovery Workflow 11/14/2025

    See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.

  10. Advanced Therapies Going Mainstream: Are We There Yet? 11/14/2025

    Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.